Insulin-like growth factor 1 signaling in human gastrointestinal carcinoid tumor cells

Jamie Joseph Van Gompel1, Herbert Chen

  • 1Department of Surgery, University of Wisconsin Comprehensive Cancer Center, 600 Highland Avenue, Madison, WI 53792, USA.

Surgery
|January 20, 2005
PubMed

Insights

Activating the raf-1/MEK1 pathway blocks insulin-like growth factor 1 (IGF-1) effects on neuroendocrine hormone regulation in carcinoid tumors. This suggests raf-1/MEK1 activation is a potential therapeutic strategy for gastrointestinal carcinoid tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Insulin-like growth factor 1 (IGF-1) acts as an autocrine regulator in carcinoid tumors.
  • Blocking IGF-1 signaling is a potential therapeutic strategy for carcinoid syndrome.
  • The study investigates the role of parallel raf-1/MEK1 pathways in modulating IGF-1 signaling.

Purpose of the Study:

  • To determine if activating raf-1/MEK1 pathways can counteract IGF-1-mediated chromogranin A (CgA) maintenance.
  • To explore the therapeutic potential of raf-1/MEK1 pathway activation in gastrointestinal carcinoid tumors.

Main Methods:

  • Human gastrointestinal carcinoid tumor cells (BON) were treated with varying concentrations of IGF-1.
  • Raf-1/MEK1 activation was induced using an estrogen-inducible raf-1 vector.
  • Phosphorylation of downstream targets (p70s6, ERK1/2) and CgA levels were measured to assess pathway activation and hormone regulation.

Main Results:

  • IGF-1 and raf-1 pathways were successfully activated in BON cells, indicated by increased phosphorylation of p70s6 and ERK1/2.
  • IGF-1 treatment stimulated CgA release and maintained high intracellular CgA levels.
  • Activation of the raf-1/MEK1 pathway reversed IGF-1's effects, leading to depletion of intracellular CgA.

Conclusions:

  • Induction of the raf-1/MEK1 pathway effectively blocks IGF-1-mediated regulation of intracellular neuroendocrine hormones like CgA.
  • Raf-1/MEK1 pathway activation presents a promising therapeutic target for managing IGF-1-mediated cellular effects in gastrointestinal carcinoid tumors.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...